Market Cap 4.04B
Revenue (ttm) 10.90M
Net Income (ttm) -322.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,956.88%
Debt to Equity Ratio 0.00
Volume 2,724,621
Avg Vol 1,682,276
Day's Range N/A - N/A
Shares Out 120.52M
Stochastic %K 83%
Beta 0.91
Analysts Strong Sell
Price Target $66.56

Company Profile

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. The company's pipeline has three programs in registrational clinical trials, such as Delpacibart etedesiran, which is in Phase 3 development stag...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 401 7900
Address:
10578 Science Center Drive, Suite 125, San Diego, United States
Count_Von_Count
Count_Von_Count Jul. 18 at 7:28 PM
$RNA started a position
0 · Reply
msonfive
msonfive Jul. 17 at 6:48 PM
$RNA WHEN $LLY BO?
0 · Reply
Hello_AI
Hello_AI Jul. 15 at 5:20 AM
$RNA 45 in 1 month...!!
0 · Reply
le_tye88
le_tye88 Jul. 9 at 5:20 PM
$RNA once we break $33, next stop will be $40+
0 · Reply
AdiDasRom
AdiDasRom Jul. 9 at 4:24 PM
$RNA Oau
0 · Reply
Hello_AI
Hello_AI Jun. 30 at 11:37 PM
$RNA waiting
0 · Reply
Florestan
Florestan Jun. 27 at 10:19 PM
$RNA I believe del-zota will fail its Q4 readout. It is likely to recreate $SRPT's EMBARK topline.
1 · Reply
JarvisFlow
JarvisFlow Jun. 27 at 1:00 PM
Cantor Fitzgerald updates rating for Avidity Biosciences ( $RNA ) to Overweight, target set at 96.
0 · Reply
Ohzipit
Ohzipit Jun. 26 at 12:16 PM
$RNA RJ Strong buy partial report
0 · Reply
Ohzipit
Ohzipit Jun. 24 at 11:00 PM
$VKTX New Biotech analyst at RJF …some general comments on small/mid cap biotech not specific to Viking as he follows other stocks in the sector (strong buy rating on $RNA and $DYN ) but I find very timely as the sector has dramatically underperformed for years. Eventually will revert to the mean and de-risked, well funded late stage companies seem to be the place to be. GL
2 · Reply
Latest News on RNA
Avidity Biosciences Honors Rare Disease Day®

Feb 29, 2024, 12:00 PM EST - 1 year ago

Avidity Biosciences Honors Rare Disease Day®


Avidity Stock Soars on Collaboration Deal With Bristol Myers

Nov 28, 2023, 7:43 AM EST - 1 year ago

Avidity Stock Soars on Collaboration Deal With Bristol Myers

BMY


Count_Von_Count
Count_Von_Count Jul. 18 at 7:28 PM
$RNA started a position
0 · Reply
msonfive
msonfive Jul. 17 at 6:48 PM
$RNA WHEN $LLY BO?
0 · Reply
Hello_AI
Hello_AI Jul. 15 at 5:20 AM
$RNA 45 in 1 month...!!
0 · Reply
le_tye88
le_tye88 Jul. 9 at 5:20 PM
$RNA once we break $33, next stop will be $40+
0 · Reply
AdiDasRom
AdiDasRom Jul. 9 at 4:24 PM
$RNA Oau
0 · Reply
Hello_AI
Hello_AI Jun. 30 at 11:37 PM
$RNA waiting
0 · Reply
Florestan
Florestan Jun. 27 at 10:19 PM
$RNA I believe del-zota will fail its Q4 readout. It is likely to recreate $SRPT's EMBARK topline.
1 · Reply
JarvisFlow
JarvisFlow Jun. 27 at 1:00 PM
Cantor Fitzgerald updates rating for Avidity Biosciences ( $RNA ) to Overweight, target set at 96.
0 · Reply
Ohzipit
Ohzipit Jun. 26 at 12:16 PM
$RNA RJ Strong buy partial report
0 · Reply
Ohzipit
Ohzipit Jun. 24 at 11:00 PM
$VKTX New Biotech analyst at RJF …some general comments on small/mid cap biotech not specific to Viking as he follows other stocks in the sector (strong buy rating on $RNA and $DYN ) but I find very timely as the sector has dramatically underperformed for years. Eventually will revert to the mean and de-risked, well funded late stage companies seem to be the place to be. GL
2 · Reply
AdiDasRom
AdiDasRom Jun. 18 at 1:46 PM
$RNA Gold
0 · Reply
Str8Goods
Str8Goods Jun. 17 at 7:10 PM
$RNA But then again, the Institutions own shares worth more than the current market cap. This means that Institutions bought well over the current share price, if the following information is correct. https://www.nasdaq.com/market-activity/stocks/rna/institutional-holdings
0 · Reply
Str8Goods
Str8Goods Jun. 17 at 6:53 PM
$RNA Too much insider selling for me. GLTA
0 · Reply
Str8Goods
Str8Goods Jun. 17 at 3:25 PM
$RNA $RNA Hedge Fund Activity Here are some of the largest recent moves: JANUS HENDERSON GROUP PLC added 4,373,686 shares (+62.0%) to their portfolio in Q1 2025, for an estimated $129,111,210 WELLINGTON MANAGEMENT GROUP LLP added 1,578,459 shares (+19.5%) to their portfolio in Q1 2025, for an estimated $46,596,109 BANK OF AMERICA CORP /DE/ added 1,395,900 shares (+781.6%) to their portfolio in Q1 2025, for an estimated $41,206,968 FMR LLC removed 894,542 shares (-5.4%) from their portfolio in Q1 2025, for an estimated $26,406,879 BOXER CAPITAL MANAGEMENT, LLC removed 862,388 shares (-49.9%) from their portfolio in Q1 2025, for an estimated $25,457,693 RTW INVESTMENTS, LP added 814,056 shares (+10.3%) to their portfolio in Q1 2025, for an estimated $24,030,933 T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 771,158 shares (+inf%) to their portfolio in Q1 2025, for an estimated $22,764,584
0 · Reply
JarvisFlow
JarvisFlow Jun. 17 at 1:28 PM
Wolfe Research updates rating for Avidity Biosciences ( $RNA ) to Outperform, target set at 55.
0 · Reply
Str8Goods
Str8Goods Jun. 17 at 12:04 PM
$RNA Just crossed my watch list. Can anyone tell me the difference between Avidity (RNA) and Sarepta (SRPT)? SRPT also had high expectations from Analysts until recently when a patient died from complications. I'm looking through materials now and their most recent Website Presentation. If anyone has information they would like to share it would be appreciated.
0 · Reply
4Reel
4Reel Jun. 16 at 8:50 PM
$RNA another big price target here. $55, while stock sits under 30 dollars and the entire float is pretty much owned by tutes. A lot of retail quiet and forgot about this as its trekked down. It will rise up again soon
0 · Reply
ChessGM
ChessGM Jun. 11 at 7:47 PM
$RNA Raymond James Reinstates Strong Buy on Disc Medicine, Announces $89 Price Target
0 · Reply
JarvisFlow
JarvisFlow Jun. 11 at 3:56 PM
Raymond James has updated their rating for Avidity Biosciences ( $RNA ) to Strong Buy with a price target of 65.
0 · Reply
anachartanalyst
anachartanalyst Jun. 10 at 8:02 PM
$RNA https://anachart.com/wp-content/uploads/ana_temp/1749585707_soc-img.jpg
0 · Reply
topstockalerts
topstockalerts Jun. 10 at 1:46 PM
$RNA can she push higher?🍾🍾
0 · Reply
JarvisFlow
JarvisFlow Jun. 10 at 1:10 PM
Citigroup has updated their rating for Avidity Biosciences ( $RNA ) to Buy with a price target of 75.
0 · Reply